胰岛素样生长因子结合蛋白2:在扩大心肌病症中,左心室功能障碍的核心生物标志物
Wei Yu1,2, Hongli Gao1, Tianyang Hu3
1Department of Cardiology, The Yongchuan Hospital of Chongqing Medical University, Chongqing, China.
Hereditas
|October 31, 2023
概括
RNA修饰调节器是扩张性心肌病 (DCM) 的关键. 胰岛素样生长因子结合蛋白2 (IGFBP2) 被确定为DCM患者左心室功能障碍的生物标志物.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 心血管研究研究心血管研究
背景情况:
- RNA的修改,包括N6-甲基氨酸,N1-甲基氨酸和5-甲基氨酸,都与心血管疾病的进展有关.
- 在扩张性心肌病 (DCM) 中RNA修饰调节器 (RMRs) 的特定作用仍然在很大程度上未被定义.
研究的目的:
- 确定参与DCM的关键RNA修饰调节器 (RMR).
- 开发和验证使用已识别的RMR用于DCM的风险预测模型.
- 探索这些RMR在DCM中的临床相关性.
主要方法:
- 使用三种机器学习模型选RMR.
- 基于关键RMR的DCM风险预测模型的开发和验证.
- 与临床特征的相关性分析和动物模型和人类实验对象的验证.
- 鉴定基因的单细胞表达分析.
主要成果:
- 确定了四个关键的RMR,形成了DCM准确而敏感的风险预测模型.
- 胰岛素样生长因子结合蛋白2 (IGFBP2) 与左心室喷射分数 (LVEF) 的相关性最强.
- 在DCM模型和患者中,IGFBP2被显著上调,与LVEF呈负相关性. 单细胞分析表明其主要表达在内皮细胞中.
结论:
- 在DCM中,IGFBP2作为左心室功能障碍的显著生物标志物.
- IGFBP2具有作为DCM治疗中未来临床应用的治疗点的潜力.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
99
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
99
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
174
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
174
Heart Failure II: Pathophysiology
14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12


